NEWARK, Del, April 20, 2023 (GLOBE NEWSWIRE) -- The global Drug Discovery Services Market size is projected to garner significant growth from 2023 to 2033. According to the research report, the global market is anticipated to surpass a valuation of US$ 19.7 billion in 2023. It is likely to hit a valuation of US$ 76.5 billion by 2033. The market is projected to thrive at a CAGR of 14.5% from 2023 to 2033.
The demand for drugs is swelling to treat chronic disorders and unmet medical needs. The developing market for pharmaceuticals is augmenting the market share for drug discovery services. Market growth is likely to be amplified by technological advancements. Additionally, there has been a rise in the use of innovative discovery methods in recent years. For instance, mass spectrometry is a proteomics technique used to uncover every stage of oncology drug discovery.
Get a PDF Sample with Latest Market Insights@ https://www.futuremarketinsights.com/reports/sample/rep-gb-14258
Rising drug distribution is a result of escalating generic medicine demand and an increase in patent expirations. Demand for drug discovery services is increasing due to expanding healthcare sector and the rising demand for generic drugs. The aging population, as well as technological advancements in drug discovery services, aid the market's rapid expansion.
Discovering and developing new drugs can incur huge costs and time. The need for specialization in different scientific fields grows as drug research becomes more difficult. Toxicology, medicinal chemistry, pharmacology, and formulation development experts are typically involved in the development of new medications. Research organizations and pharmaceutical businesses can cut costs and time by outsourcing these services. Without making significant expenditures, the market for outsourced drug delivery services offers access to specialized infrastructure and knowledge.
North America is anticipated to dominate global market shares. The drug discovery services industry in the region operates as a free market with transparent trading practices and restrictions on anti-competitive behavior. The market for biosimilars in the United States is growing tremendously as biologics are more expensive in the region.
Key Takeaways from Drug Discovery Services Market:
- In 2022, the global drug discovery services market size stood at US$ 17.5 billion.
- The pharmaceutical companies segment accounted for 42% market share in 2022.
- In terms of market share, the Hit-to-lead identification method is the dominant segment.
- During the projection period, the biological services segment in the market is expected to increase at a high CAGR.
- The oncology segment accounted for an impressive 39.7% market share in 2022.
- North America accounted for a massive 35.2% market share in 2022.
Ask from Market Research Expert@ https://www.futuremarketinsights.com/ask-question/rep-gb-14258
Recent Developments Observed by FMI:
- Genentech announced in January 2023 that it had been granted Priority Review and Fast Track designation for Glofitamab. To treat adult patients with refractory or relapsing LBCL, the medication, a new bispecific antibody, activates immune system T-cells.
- Brexpiprazole, an atypical antipsychotic supplement NDA authorized for schizophrenia, was released in January 2023 under FDA Priority Review. Brexpiprazole was developed by H. Lundbeck A/S and Otsuka Pharmaceuticals.
- The FDA approved UCB's Rozanolixizumab for additional Phase III research in January 2023.
- Harm Reduction Therapeutics announced about RiVive in December 2022. As the FDA accepted and awarded Priority for Review to their new drug application. The product is an over-the-counter nasal spray form of naloxone.
Key Players in the Market
- Laboratory Corporation of America Holdings
- Charles River Laboratories International Inc.
- Genscript Biotech Corporation
- Thermo Fisher Scientific Inc.
- Pharmaron Beijing Co. Ltd.
- Evotec SE
- Eurofins Scientific SE
- Pharmaceutical Product Development Inc.
- Piramal Enterprise Limited
- Syngene International Limited
Market Segmentation
By Process:
- Target Selection
- Target Validation
- Hit-to-lead identification
- Lead Optimization
- Candidate Validation
By Type:
- Chemistry Services
- Biology Services
By Drug Type:
- Small Molecule Drugs
- Biologics Drugs
Use promo code >> FMITODAY to get flat 20% discount
By Therapeutic Area:
- Neurology
- Infectious and Immune Systems Diseases
- Digestive System Diseases
- Oncology
- Other Therapeutic Areas
By End User:
- Pharmaceutical & Biotechnology Companies
- Academic Institutes
- Manufacturing
- Other End Users
By Region:
- North America
- Latin America
- Europe
- Asia Pacific
- The Middle East & Africa
Get Full Access@ https://www.futuremarketinsights.com/reports/drug-discovery-services-market
Table of Content
1. Executive Summary | Drug Discovery Services Market
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033
4.1. Historical Market Size Value (US$ Million) Analysis, 2018 to 2022
4.2. Current and Future Market Size Value (US$ Million) Projections, 2023 to 2033
5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Process
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Million) Analysis By Process, 2018 to 2022
For more Report Customization, connect with us at@ https://www.futuremarketinsights.com/customization-available/rep-gb-14258
Explore FMI’s related ongoing Coverage on Healthcare Market Insights Domain
Brain Tumor Drugs Market Size: The brain tumor drugs market is estimated to record a 9.2% CAGR from 2023 to 2033. The market is likely to reach US$ 2.65 billion in 2023 and is expected to be worth US$ 6.30 billion in 2033.
Antibody Purification Service Market Share: Antibody purification is a critical step in the production of therapeutic antibodies, and its importance is reflected in the anticipated value pool of US$ 1 billion by the end of 2023 and a projected global demand of US$ 3 billion by 2033, marking a CAGR of 11%
Bispecific Antibody Market Demand: The global biospecific antibody market is slated to reach a market value of US$ 500 million by the end of 2023, and eventually to US$ 1 billion by 2033, marking a CAGR of 7.2%.
Discrete Analyzers Market Growth: The global discrete analyzers market is expected to enjoy a valuation of US$ 1.5 Billion in the year 2023, and further expand at a CAGR of 5.2% to reach a valuation of ~US$ 2.6 Billion by the year 2033.
Actinomycosis Market Opportunity: The actinomycosis market is anticipated to expand as society develops and looks for novel treatments for this ailment. In fact, it is expected that by 2033, global demand would be worth US$ 90 billion, growing at a CAGR of 6%.
About Future Market Insights (FMI)
Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai and has delivery centers in the UK, U.S., and India. FMI's latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.
Contact Us:
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
LinkedIn| Twitter| Blogs | YouTube
For Sales Enquiries: sales@futuremarketinsights.com
Old Source: Drug Discovery Outsourcing Market is expected to reach US$ 7.52 Billion at a CAGR of 7.2% during forecast period 2023 to 2033 | Analysis by Future Market Insights, Inc.
